Prevention and Management of Acute Renal Failure in an ICU Patient

[1]  P. Peduzzi,et al.  Intensity of renal support in critically ill patients with acute kidney injury. , 2008, The New England journal of medicine.

[2]  S. Bernstein,et al.  Meta-analysis: Effectiveness of Drugs for Preventing Contrast-Induced Nephropathy , 2008, Annals of Internal Medicine.

[3]  Anthony Delaney,et al.  Continuous versus intermittent renal replacement therapy for critically ill patients with acute kidney injury: A meta-analysis* , 2008, Critical care medicine.

[4]  C. Bekes.  Continuous renal replacement therapy is associated with less chronic renal failure than intermittent haemodialysis after acute renal failure , 2008 .

[5]  C. Becker,et al.  I.v. N-acetylcysteine and emergency CT: use of serum creatinine and cystatin C as markers of radiocontrast nephrotoxicity. , 2007, AJR. American journal of roentgenology.

[6]  O. Aslan,et al.  Sodium bicarbonate, N-acetylcysteine, and saline for prevention of radiocontrast-induced nephropathy. A comparison of 3 regimens for protecting contrast-induced nephropathy in patients undergoing coronary procedures. A single-center prospective controlled trial. , 2007, American heart journal.

[7]  I. Whyte,et al.  Safety and efficacy of intravenous N‐acetylcysteine for acetaminophen overdose: analysis of the Hunter Area Toxicology Service (HATS) database , 2007, Current medical research and opinion.

[8]  J. Kaski,et al.  The reno-protective effect of hydration with sodium bicarbonate plus N-acetylcysteine in patients undergoing emergency percutaneous coronary intervention: the RENO Study. , 2007, Journal of the American College of Cardiology.

[9]  A. Colombo,et al.  Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): A Randomized Comparison of 3 Preventive Strategies , 2007, Circulation.

[10]  R. Suojaranta-Ylinen,et al.  Lack of renoprotective effect of i.v. N-acetylcysteine in patients with chronic renal failure undergoing cardiac surgery. , 2006, British journal of anaesthesia.

[11]  J. Boyle,et al.  Does N-Acetylcysteine Prevent Contrast-Induced Nephropathy during Endovascular AAA Repair? A Randomized Controlled Pilot Study , 2006, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.

[12]  T. Perneger,et al.  Adding a dialysis dose to continuous hemofiltration increases survival in patients with acute renal failure. , 2006, Kidney international.

[13]  Gordon R Bernard,et al.  Comparison of two fluid-management strategies in acute lung injury. , 2006, The New England journal of medicine.

[14]  R. Bellomo,et al.  Extracorporeal blood purification therapies for prevention of radiocontrast-induced nephropathy: a systematic review. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[15]  J. Brinker,et al.  A meta-analysis of the renal safety of isosmolar iodixanol compared with low-osmolar contrast media. , 2006, Journal of the American College of Cardiology.

[16]  J. Chiche,et al.  Continuous venovenous haemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: a multicentre randomised trial , 2006, The Lancet.

[17]  P. Honore,et al.  The Big Bang of Hemofiltration: The Beginning of a New Era in the Third Millennium for Extra-Corporeal Blood Purification! , 2006, The International journal of artificial organs.

[18]  F. Veglia,et al.  N-Acetylcysteine and Contrast-Induced Nephropathy in Primary Angioplasty , 2006 .

[19]  N-Acetylcysteine for the Prevention of Kidney Injury in Abdominal Aortic Surgery: A Randomized, Double-Blind, Placebo-Controlled Trial , 2006, Anesthesia and analgesia.

[20]  P. Aspelin,et al.  Contrast-Induced Nephropathy: A Clinical and Evidence-Based Approach , 2006, Circulation.

[21]  G. Deray,et al.  How to prevent contrast-induced nephropathy and manage risk patients: practical recommendations. , 2006, Kidney international. Supplement.

[22]  S. Ternullo.  Acetadote (intravenous acetylcysteine): adverse effects more significant than with oral acetylcysteine. , 2006, Journal of emergency nursing: JEN : official publication of the Emergency Department Nurses Association.

[23]  P. Parfrey,et al.  Clinical practice. Preventing nephropathy induced by contrast medium. , 2006, The New England journal of medicine.

[24]  H. V. Straaten,et al.  Guidelines for timing, dose, and mode of continuous renal replacement therapy for acute renal failure in the critically ill. , 2006 .

[25]  R. Star,et al.  Design of the VA/NIH Acute Renal Failure Trial Network (ATN) study: intensive versus conventional renal support in acute renal failure , 2005, Clinical trials.

[26]  J. Takala,et al.  Comparison of continuous and intermittent renal replacement therapy for acute renal failure. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[27]  S. Bagshaw,et al.  Theophylline for prevention of contrast-induced nephropathy: a systematic review and meta-analysis. , 2005, Archives of internal medicine.

[28]  D. Staub,et al.  Incidence of contrast nephropathy in patients receiving comprehensive intravenous and oral hydration. , 2005, Swiss medical weekly.

[29]  E. Paganini,et al.  A randomized controlled trial comparing intermittent with continuous dialysis in patients with ARF. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[30]  A. Cunningham,et al.  Fenoldopam Mesylate for the Prevention of Contrast-Induced Nephropathy: A Randomized Controlled Trial , 2004 .

[31]  Jonathan Himmelfarb,et al.  Spectrum of acute renal failure in the intensive care unit: the PICARD experience. , 2004, Kidney international.

[32]  R. Schrier,et al.  Acute renal failure: definitions, diagnosis, pathogenesis, and therapy. , 2004, The Journal of clinical investigation.

[33]  R. Bersin,et al.  Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. , 2004, JAMA.

[34]  G. Marenzi,et al.  Hemofiltration in the prevention of radiocontrast agent induced nephropathy. , 2004, Minerva anestesiologica.

[35]  A. Colombo,et al.  Standard vs double dose of N-acetylcysteine to prevent contrast agent associated nephrotoxicity. , 2004, European heart journal.

[36]  David W. Johnson,et al.  Cost of acute renal failure requiring dialysis in the intensive care unit: Clinical and resource implications of renal recovery* , 2003, Critical care medicine.

[37]  J. Tijssen,et al.  Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: A prospective, randomized trial , 2002, Critical care medicine.

[38]  A. Rhodes,et al.  A randomised, controlled trial of the pulmonary artery catheter in critically ill patients , 2002, Intensive Care Medicine.

[39]  Rainald Fischer,et al.  Daily hemodialysis and the outcome of acute renal failure. , 2002, The New England journal of medicine.

[40]  R. Kaplan,et al.  A randomized clinical trial of continuous versus intermittent dialysis for acute renal failure. , 2001, Kidney international.

[41]  R Bellomo,et al.  Continuous renal replacement therapy in critically ill patients. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[42]  R. Bellomo,et al.  Intermittent versus continuous renal replacement therapy in the ICU: impact on electrolyte and acid-base balance , 2001, Intensive Care Medicine.

[43]  R. Schmieder,et al.  Effects of continuous haemofiltration vs intermittent haemodialysis on systemic haemodynamics and splanchnic regional perfusion in septic shock patients: a prospective, randomized clinical trial. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[44]  L. Brochard,et al.  Hemodynamic tolerance of intermittent hemodialysis in critically ill patients: usefulness of practice guidelines. , 2000, American journal of respiratory and critical care medicine.

[45]  Rinaldo Bellomo,et al.  Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial , 2000, The Lancet.

[46]  E. Paganini,et al.  Risk modeling in acute renal failure requiring dialysis: the introduction of a new model. , 1996, Clinical nephrology.

[47]  B. Barrett,et al.  Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. , 1993, Radiology.

[48]  A. Hughes,et al.  Anaphylactoid response to intravenous acetylcysteine , 1992, The Lancet.

[49]  A. Dawson,et al.  Adverse reactions to N‐acetylcysteine during treatment for paracetamol poisoning , 1989, The Medical journal of Australia.